References
- ChapmanKRManninoDMSorianoJBEpidemiology and costs of chronic obstructive pulmonary diseaseEur Respir J200627118820716387952
- ManninoDMEpidemiology and global impact of chronic obstructive pulmonary diseaseSemin Respir Crit Care Med200526220421016088437
- GBD 2016 Disease and Injury Incidence and Prevalence CollaboratorsGlobal, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet2017390101001211125928919117
- GBD 2015 DALYs and HALE CollaboratorsGlobal, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet2016388100531603165827733283
- PeñaVMiravitllesMGabrielRGeographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological studyChest2000118498198911035667
- MiravitllesMSorianoJBGarcía-RíoFPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activitiesThorax2009641086386819553233
- FromerLDiagnosing and treating COPD: understanding the challenges and finding solutionsInt J Gen Med2011472973922114517
- LlordésMJaénAAlmagroPPrevalence, risk factors and diagnostic accuracy of COPD among smokers in primary careCOPD2014124404412
- FriedlanderALLynchDDyarLABowlerRPPhenotypes of chronic obstructive pulmonary diseaseCOPD20074435538418027163
- HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
- MiravitllesMCalleMSoler-CataluñaJJClinical phenotypes of COPD: identification, definition and implications for guidelinesArch Bronconeumol2012483869822196477
- ZbozinkovaZBarczykATkacovaRPOPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern EuropeInt J Chron Obstruct Pulmon Dis20161161162227042048
- Global strategy for the diagnosis, management and prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2014 Available from: http://www.goldcopd.org/Accessed September 15, 2016
- MiravitllesMSoler-CataluñaJJCalleMSpanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish society of pulmonology and thoracic surgeryArch Bronconeumol201248724725722561012
- MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest19889335805863342669
- Soler-CataluñaJJMartínez-GarcíaMASánchez SánchezLPerpiñá TorderaMRomán SánchezPSevere exacerbations and BODE index: two independent risk factors for death in male COPD patientsRespir Med2009103569269919131231
- JonesPWHardingGBerryPDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
- Soler-CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol201248933133722341911
- CosíoBGSorianoJBLópez-CamposJLDefining the asthma-COPD overlap syndrome in a COPD cohortChest20161491455226291753
- Calle RubioMCasamorRMiravtllesMIdentification and distribution of COPD phenotypes in clinical practice according to Spanish COPD guidelines: the FENEPOC studyInt J Chron Obstruct Pulmon Dis2017122373238328848338
- Alcázar-NavarreteBRomero-PalaciosPJRuiz-SanchoARuiz-RodriguezODiagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypesNitric Oxide201654677226916083
- KoblizekVMilenkovicBBarczykAPhenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE StudyEur Respir J201749160144628495687